Urgent Care Management of Respiratory Illness Enabled With Novel Testing Pathway

NACompletedINTERVENTIONAL
Enrollment

360

Participants

Timeline

Start Date

April 4, 2022

Primary Completion Date

January 1, 2023

Study Completion Date

June 1, 2023

Conditions
Viral InfectionAcute Respiratory InfectionUpper Resp Tract Infection
Interventions
DIAGNOSTIC_TEST

BioFire® Respiratory Panel 2.1-EZ

BioFire RP2.1-EZ Panel uses a syndromic approach to quickly identify SARS-CoV-2, along with 18 additional viral and bacterial pathogens in patients suspected of SARS-CoV-2. This PCR test provides results in about 45 minutes.

Trial Locations (2)

20005

GW Immediate & Primary Care - McPherson Square, Washington D.C.

20018

GW Immediate & Primary Care - Rhode Island Ave, Washington D.C.

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

BioMérieux

INDUSTRY

lead

Andrew Meltzer

OTHER